M&A

AbbVie, Allergan merger may face regulatory delay due to COVID-19: report
Fierce Pharma
Tue, 03/17/20 - 11:32 pm
AbbVie
Allergan
FTC
M&A
COVID-19
Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap
Endpoints
Mon, 03/16/20 - 11:02 am
antibiotics
Tetraphase
M&A
AcelRx
Bristol Myers flunks frontline multiple myeloma trial, turning attention to cell therapy
Endpoints
Mon, 03/9/20 - 10:52 am
Bristol-Myers Squibb
Celgene
M&A
clinical trials
Multiple Myeloma
Empliciti
AbbVie
Revlimid
Can Gilead Change Its Dim Fortunes On An Immuno-Oncology Buyout?
Investors Business Daily
Sat, 03/7/20 - 07:41 pm
Gilead Scinecs
M&A
Forty Seven
immuno-oncology
Shionogi boosts Tetra Alzheimer's deal, nabs buyout option
Fierce Biotech
Fri, 03/6/20 - 11:41 pm
Shionogi
Tetra Therapeutics
R&D
M&A
Bristol Myers Squibb unveils new branding, will phase out Celgene brand
Medical Marketing and Media
Thu, 03/5/20 - 10:27 am
Bristol-Myers Squibb
Celgene
rebranding
M&A
AbbVie and Allergan finally set (rough) date for wedding as one parent agrees to the match
Endpoints
Wed, 03/4/20 - 10:54 am
AbbVie
Allergan
M&A
Exact Sciences Acquires 2 Cancer Diagnostic Companies
Motley Fool
Wed, 03/4/20 - 12:05 am
EXACT Sciences
M&A
diagnostics
cancer
Paradigm Diagnostics
Viomics
Thermo Fisher Scientific Set to Acquire Qiagen for $11.5B
Medical Devices and Diagnostics Industry
Tue, 03/3/20 - 11:27 am
ThermoFisher Scientific
Qiagen
M&A
diagnostics
Waksal's bid for Redx ends, forcing biotech to avert cash crunch
Fierce Biotech
Mon, 03/2/20 - 10:35 am
Redx
Sam Waksal
M&A
Gilead strikes $4.9B Forty Seven acquisition, paying a hefty premium for cancer drug
Fierce Biotech
Mon, 03/2/20 - 10:13 am
Gilead Sciences
M&A
Forty Seven
CD-47
BioPharma M&A Drives More Efficient Resource Allocation
Forbes
Mon, 03/2/20 - 09:58 am
M&A
resource allocation
Medtronic Rumored to Be Looking at a Deal with LivaNova
Medical Devices and Diagnostics Industry
Sun, 03/1/20 - 07:57 pm
Medtronic
devices
M&A
neuromodulation
LivaNova
Gilead hungry for 'don't eat me' cancer biotech: reports
Fierce Biotech
Fri, 02/28/20 - 10:51 am
Gilead Sciences
Forty Seven
cancer
M&A
Pharmacquired: Where are all the deals?
BioPharma Dive
Thu, 02/27/20 - 10:46 am
M&A
Gilead Sciences
Biogen
Sanofi
Eli Lilly
GSK
Merck
Vertex Pharmaceuticals
Iovance shares jump on buyout rumors
Fierce Biotech
Wed, 02/26/20 - 10:40 am
immuno-oncology
Iovance
M&A
Takeda Acquires Celiac-Focused PvP Biologics in Deal Worth $330 Million
BioSpace
Wed, 02/26/20 - 10:34 am
Takeda
PvP Biologics
celiac disease
M&A
TAK-062
Medtronic acquires AI specialist Digital Surgery
Pharmaforum
Wed, 02/19/20 - 10:01 am
Medtronic
devices
Digital Surgery
M&A
artificial intelligence
Melinta seeks buyout bids to secure escape from bankruptcy
Fierce Biotech
Fri, 02/14/20 - 10:43 am
Melinta Therapeutics
M&A
bankruptcy
Biopharma’s big bet on cancer is laid bare
EP Vantage
Fri, 02/14/20 - 10:39 am
cancer
oncology
M&A
licensing

Pages